Quantum BioPharma Ltd. (CSE:QNTM)
Canada
· Delayed Price · Currency is CAD 7.40
+1.31 (21.51%)
At close: Apr 28, 2026
Quantum BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.91 | 6 | 2.76 | 16.98 | 35.26 | Upgrade
|
| Short-Term Investments | 0.46 | 1.2 | 0.76 | - | 0.16 | Upgrade
|
| Cash & Short-Term Investments | 2.36 | 7.2 | 3.51 | 16.98 | 35.42 | Upgrade
|
| Cash Growth | -67.15% | 104.89% | -79.31% | -52.06% | 102.10% | Upgrade
|
| Accounts Receivable | - | 3.43 | 7.19 | 0.02 | - | Upgrade
|
| Other Receivables | 0.23 | 0.37 | 0.23 | 0.37 | 0.5 | Upgrade
|
| Receivables | 0.23 | 3.81 | 7.42 | 0.4 | 0.5 | Upgrade
|
| Inventory | 0.05 | 0.12 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.02 | 0.04 | 0.12 | 0.16 | 0.76 | Upgrade
|
| Other Current Assets | 3.82 | 0.89 | 0.03 | 0.31 | 9.25 | Upgrade
|
| Total Current Assets | 6.48 | 12.05 | 11.09 | 17.85 | 45.93 | Upgrade
|
| Property, Plant & Equipment | 0.17 | 0.13 | 0.12 | 0.26 | 0.17 | Upgrade
|
| Long-Term Investments | - | 0 | 0.01 | 0.83 | 0.66 | Upgrade
|
| Other Intangible Assets | 4.51 | 4.93 | 5.36 | 12.04 | 16.2 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0.91 | 7.43 | - | Upgrade
|
| Total Assets | 11.16 | 17.12 | 17.47 | 38.41 | 62.96 | Upgrade
|
| Accounts Payable | 1.98 | 3.25 | 3.24 | 2.76 | 3 | Upgrade
|
| Accrued Expenses | 2.2 | 1.11 | 0.95 | 4.35 | 4.46 | Upgrade
|
| Short-Term Debt | 1.3 | 0.62 | 0.3 | 0.3 | 0.3 | Upgrade
|
| Current Portion of Long-Term Debt | 0.47 | 0.15 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.1 | 0.05 | 0.04 | 0.18 | 0.12 | Upgrade
|
| Current Unearned Revenue | - | 1 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 0.49 | 0.03 | 0.24 | 0.83 | Upgrade
|
| Total Current Liabilities | 6.06 | 6.68 | 4.57 | 7.83 | 8.7 | Upgrade
|
| Long-Term Leases | - | - | - | 0.04 | 0.13 | Upgrade
|
| Total Liabilities | 6.06 | 6.68 | 4.57 | 7.87 | 8.83 | Upgrade
|
| Common Stock | 169.7 | 150.47 | 137.78 | 143.41 | 152.32 | Upgrade
|
| Additional Paid-In Capital | 35.41 | 31.07 | 30.23 | 28.5 | 22.58 | Upgrade
|
| Retained Earnings | -198.29 | -172.11 | -157.91 | -144.16 | -126.15 | Upgrade
|
| Comprehensive Income & Other | 0.1 | 2.05 | 3.14 | 2.8 | 5.38 | Upgrade
|
| Total Common Equity | 6.92 | 11.48 | 13.24 | 30.54 | 54.13 | Upgrade
|
| Minority Interest | -1.82 | -1.04 | -0.33 | - | - | Upgrade
|
| Shareholders' Equity | 5.1 | 10.44 | 12.91 | 30.54 | 54.13 | Upgrade
|
| Total Liabilities & Equity | 11.16 | 17.12 | 17.47 | 38.41 | 62.96 | Upgrade
|
| Total Debt | 1.88 | 0.82 | 0.34 | 0.52 | 0.56 | Upgrade
|
| Net Cash (Debt) | 0.49 | 6.37 | 3.17 | 16.46 | 34.86 | Upgrade
|
| Net Cash Growth | -92.34% | 100.80% | -80.72% | -52.77% | 104.90% | Upgrade
|
| Net Cash Per Share | 0.15 | 5.61 | 5.21 | 27.63 | 64.84 | Upgrade
|
| Filing Date Shares Outstanding | 5.83 | 2.71 | 0.62 | 0.63 | 0.59 | Upgrade
|
| Total Common Shares Outstanding | 3.89 | 2.3 | 0.61 | 0.59 | 0.62 | Upgrade
|
| Working Capital | 0.42 | 5.37 | 6.52 | 10.02 | 37.23 | Upgrade
|
| Book Value Per Share | 1.78 | 4.99 | 21.85 | 51.56 | 86.98 | Upgrade
|
| Tangible Book Value | 2.41 | 6.55 | 7.88 | 18.5 | 37.93 | Upgrade
|
| Tangible Book Value Per Share | 0.62 | 2.85 | 13.01 | 31.23 | 60.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.